EUVIMEDOpdag EUVIMED
Crossref

Increased prescription dose for large vessel intravascular brachytherapy

Kent Wallner iD, Kathleen E Kearney, Jasleen Tiwana, Nicole Pristera, Edward Y Kim, Lorenzo Azzalini iD, George Sandison, William L Lombardi, Creighton Don, Minsun Kim

Catheterization and Cardiovascular Interventions · 2023

DOI: 10.1002/ccd.30852 ↗

At a glance

Journal article in Catheterization and Cardiovascular Interventions, 2023. Written by Kent Wallner and 9 co-authors. Institution: Departments of Radiation Oncology, University of Washington, Seattle, Washington, USA. Major MEDLINE topics: Brachytherapy, Coronary Restenosis. 20 references.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background

Most randomized studies testing the effectiveness of IVBT were limited to vessels less than 4 mm diameter. In fact, it is now common to treat vessels larger than 4 mm. Accordingly, the authors instituted a prescription dose increase to 34 Gy at 2 mm from source center for vessels greater than 4.0 mm. The increase in prescription dose to 34 Gy at 2 mm from center is substantial, being 50% higher than the conventional maximum of 23 Gy.

Aim

To take a close look at group of patients treated to 34 Gy, and for whom follow‐up angiograms are available.

Methods

Ten patients treated for ISR with a prescription dose of 34 Gy and for whom follow‐up angiograms were available were studied. Beta‐radiation brachytherapy was performed with a Novoste Beta‐Cath System using a strontium‐90 (beta) source (Best Vascular, Springfield, VA). Source lengths of 40 or 60 mm were used. A dose of 34 Gy was prescribed at 2 mm from the source center.

Results

Patients were re‐catheterized from 2 to 21 months (median: 16 months) following IVBT, all for symptoms suggested of restenosis. All patients had some degree of ISR of the target vessel, but no IVBT‐treated vascular segment showed angiographic signs of degeneration, dissection or aneurysm.

Conclusion

The authors' clinical impression, along with detailed review of the 10 cases, suggest that using a 34 Gy prescription dose at 2 mm from source center does not result in increased toxicity.

Subjects

MeSH terms (MEDLINE)

BrachytherapyCoronary RestenosisHumansTreatment OutcomeCatheterizationVascular Surgical ProceduresStents

Author keywords

brachytherapycardiaccoronarydosimetryradiationrestenosis

Authors and institutions

  • Departments of Radiation Oncology, University of Washington, Seattle, Washington, USA.
  • Department of Medicine, Division of Cardiology, University of Washington, Seattle, Washington, USA.

ORCID profiles: Kent Wallner, Lorenzo Azzalini

Cite

APA

Wallner, K., Kearney, K. E., Tiwana, J., Pristera, N., Kim, E. Y., Azzalini, L., Sandison, G., Lombardi, W. L., Don, C., & Kim, M. (2023). Increased prescription dose for large vessel intravascular brachytherapy. Catheterization and Cardiovascular Interventions. https://doi.org/10.1002/ccd.30852

Vancouver

Wallner K, Kearney KE, Tiwana J, Pristera N, Kim EY, Azzalini L, et al. Increased prescription dose for large vessel intravascular brachytherapy. Catheterization and Cardiovascular Interventions. 2023. doi:10.1002/ccd.30852

BibTeX
@article{Wallner2023,
  author = {Wallner, Kent and Kearney, Kathleen E and Tiwana, Jasleen and Pristera, Nicole and Kim, Edward Y and Azzalini, Lorenzo and Sandison, George and Lombardi, William L and Don, Creighton and Kim, Minsun},
  title = {Increased prescription dose for large vessel intravascular brachytherapy},
  journal = {Catheterization and Cardiovascular Interventions},
  year = {2023},
  doi = {10.1002/ccd.30852}
}
Start for free →